Newsquawk Logo

Ventyx Biosciences (VTYX) takeover deal with Eli Lilly (LLY) is reportedly being debated at USD 14/shr in cash; could be announced later today, according to the WSJ

The potential takeover of Ventyx Biosciences by Eli Lilly at $14 per share could indicate strategic consolidation in the pharmaceuticals sector, particularly in biotechnology.

Newsquawk StaffPublished On the live feed at — 6 more headlines followed before this page went public
Newsquawk headlinesUTC

PREVIEW: US Nonfarm Payrolls due 9th January at 13:30GMT/08:30EST

US President Trump posts "We will always be there for NATO, even if they won’t be there for us. The only Nation that China and Russia fear and respect is the DJT REBUILT U.S.A."

Ventyx Biosciences (VTYX) takeover deal with Eli Lilly (LLY) is reportedly being debated at USD 14/shr in cash; could be announced later today, according to the WSJ

Russian Foreign Minister says the Marinera tanker is a Russian vessel and expresses concern around the situation

US Southern Command says the DoW "apprehended a stateless, sanctioned dark fleet motor tanker without incident"; "The interdicted vessel, M/T Sophia, was operating in international waters and conducting illicit activities in the Caribbean Sea"

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

If confirmed, this deal might set a precedent for further M&A activity in the space, while boosting Eli Lilly's position in the market. Traders should monitor the stock reactions and implications for both companies, including any changes in valuation or competitive dynamics within the industry.

External

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.